{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:19:33Z","timestamp":1779236373162,"version":"3.51.4"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T00:00:00Z","timestamp":1603238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T00:00:00Z","timestamp":1603238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s40266-020-00808-4","type":"journal-article","created":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T01:02:42Z","timestamp":1603242162000},"page":"779-785","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The Cross-Talk between Age, Hypertension and Inflammation in COVID-19 Patients: Therapeutic Targets"],"prefix":"10.1007","volume":"37","author":[{"given":"Gerardo","family":"Casucci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"Acanfora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaele Antonelli","family":"Incalzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,21]]},"reference":[{"key":"808_CR1","unstructured":"Coronavirus Map: tracking the global outbreak. The New York Times. Updated 15 May 2020."},{"key":"808_CR2","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054\u201362. https:\/\/doi.org\/10.1016\/S0140-6736(20)30566-3.","journal-title":"Lancet"},{"issue":"5","key":"808_CR3","doi-asserted-by":"publisher","first-page":"2000524","DOI":"10.1183\/13993003.00524-2020","volume":"55","author":"RH Du","year":"2020","unstructured":"Du RH, Liang LR, Yang CQ, et al. Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study. Eur Respir J. 2020;55(5):2000524. https:\/\/doi.org\/10.1183\/13993003.00524-2020.","journal-title":"Eur Respir J"},{"issue":"6","key":"808_CR4","doi-asserted-by":"publisher","first-page":"2000562","DOI":"10.1183\/13993003.00562-2020","volume":"55","author":"WH Liang","year":"2020","unstructured":"Liang WH, Guan WJ, Li CC, et al. Clinical characteristics and outcomes of hospitalised patients with COVID-19 treated in Hubei (epicenter) and outside Hubei (non-epicenter): a nationwide analysis of China. Eur Respir J. 2020;55(6):2000562. https:\/\/doi.org\/10.1183\/13993003.00562-2020.","journal-title":"Eur Respir J"},{"key":"808_CR5","unstructured":"Istituto Superiore di Sanit\u00e0 Caratteristiche dei pazienti deceduti positivi a COVID-19 in Italia. 2019. www.epicentro.iss.it\/coronavirus\/bollettino\/Report-COVID-2019_2_aprile_eng.pdf."},{"issue":"6","key":"808_CR6","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/j.mayocp.2020.03.026","volume":"95","author":"F Sanchis-Gomar","year":"2020","unstructured":"Sanchis-Gomar F, Lavie CJ, Perez-Quilis C, Henry BM, Lippi G. Angiotensin-converting enzyme 2 and antihypertensives (angiotensin receptor blockers and angiotensin-converting enzyme inhibitors) in coronavirus disease 2019. Mayo Clin Proc. 2020;95(6):1222\u2013300. https:\/\/doi.org\/10.1016\/j.mayocp.2020.03.026.","journal-title":"Mayo Clin Proc"},{"issue":"9","key":"808_CR7","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1016\/j.mayocp.2020.06.046","volume":"95","author":"A Sharma","year":"2020","unstructured":"Sharma A, Garg A, Rout A, Lavie CJ. Association of Obesity With More Critical Illness in COVID-19. Mayo Clin Proc. 2020;95(9):2040\u20132. https:\/\/doi.org\/10.1016\/j.mayocp.2020.06.046.","journal-title":"Mayo Clin Proc"},{"key":"808_CR8","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.micinf.2020.02.002","volume":"22","author":"JY Li","year":"2020","unstructured":"Li JY, You Z, Wang Q, et al. The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future. Microbes Infect. 2020;22:80\u20135. https:\/\/doi.org\/10.1016\/j.micinf.2020.02.002(Epub 2020 Feb 20).","journal-title":"Microbes Infect"},{"key":"808_CR9","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"382","author":"WJ Guan","year":"2020","unstructured":"Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of 2019 novel coronavirus infection in China. N Engl J Med. 2020;382:1708\u201320. https:\/\/doi.org\/10.1056\/NEJMoa2002032.","journal-title":"N Engl J Med"},{"key":"808_CR10","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","volume":"8","author":"X Yang","year":"2020","unstructured":"Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8:475\u201381.","journal-title":"Lancet Respir Med"},{"issue":"20","key":"808_CR11","doi-asserted-by":"publisher","first-page":"30136","DOI":"10.1016\/j.ijid.2020.03.017","volume":"9712","author":"J Yang","year":"2020","unstructured":"Yang J, Zheng Y, Gou X, et al. Prevalence of comorbidities in the novel Wuhan coronavirus (Covid-19) infection: a systematic review and meta-analysis. Int J Infect Dis. 2020;9712(20):30136\u201343. https:\/\/doi.org\/10.1016\/j.ijid.2020.03.017.","journal-title":"Int J Infect Dis"},{"key":"808_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2019.00001","volume":"10","author":"L Guo","year":"2019","unstructured":"Guo L, Wei D, Zhang X, Wu Y, Li Q, Zhou M, Qu J. Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score. Front Microbiol. 2019;10:1\u201310.","journal-title":"Front Microbiol"},{"key":"808_CR13","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet. 2020;395:1054\u201362.","journal-title":"The Lancet"},{"issue":"7","key":"808_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/jamainternmed.2020.0994","volume":"180","author":"C Wu","year":"2020","unstructured":"Wu C, Chen X, Cai Y, Xia J, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020;180(7):1\u201311. https:\/\/doi.org\/10.1001\/jamainternmed.2020.0994.","journal-title":"JAMA Intern Med."},{"key":"808_CR15","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvaa097","author":"R Kreutz","year":"2020","unstructured":"Kreutz R, Abd-El-Hady AE, Azizi M, et al. Hypertension, the renin-angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19. Cardiov Res. 2020. https:\/\/doi.org\/10.1093\/cvr\/cvaa097.","journal-title":"Cardiov Res."},{"key":"808_CR16","doi-asserted-by":"publisher","DOI":"10.1101\/2020.04.05.20054155","author":"K Matsushita","year":"2020","unstructured":"Matsushita K, Ding N, Kou M, et al. The relationship of COVID-19 severity with cardiovascular disease and its traditional risk factors: A systematic review and meta-analysis. medRxiv. 2020. https:\/\/doi.org\/10.1101\/2020.04.05.20054155.","journal-title":"medRxiv."},{"issue":"7798","key":"808_CR17","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","volume":"579","author":"F Wu","year":"2020","unstructured":"Wu F, Zhao S, Yu B, Chen Y-M, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579(7798):265\u20139. https:\/\/doi.org\/10.1038\/s41586-020-2008-3.","journal-title":"Nature"},{"key":"808_CR18","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/01.RES.87.5.e1","volume":"87","author":"M Donoghue","year":"2000","unstructured":"Donoghue M, Hsieh F, Baronas E, et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin i to angiotensin 1\u20139. Circ Res. 2000;87:e1\u2013e9.","journal-title":"Circ Res"},{"key":"808_CR19","doi-asserted-by":"publisher","first-page":"33238","DOI":"10.1074\/jbc.M002615200","volume":"275","author":"SR Tipnis","year":"2000","unstructured":"Tipnis SR, Hooper NM, Hyde R, et al. A human homolog of angiotensin-converting enzyme cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem. 2000;275:33238\u201343.","journal-title":"J Biol Chem"},{"key":"808_CR20","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1161\/01.HYP.0000063886.71596.C8","volume":"41","author":"Y Yagil","year":"2003","unstructured":"Yagil Y, Yagil C. Hypothesis ACE2 modulates blood pressure in the mammalian organism. Hypertension. 2003;41:871\u20133.","journal-title":"Hypertension"},{"key":"808_CR21","doi-asserted-by":"publisher","first-page":"715","DOI":"10.2174\/1381612033455431","volume":"9","author":"RP Marshall","year":"2003","unstructured":"Marshall RP. The pulmonary renin-angiotensin system. Curr Pharm Des. 2003;9:715\u201322.","journal-title":"Curr Pharm Des"},{"key":"808_CR22","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.coph.2006.03.001","volume":"6","author":"K Kuba","year":"2006","unstructured":"Kuba K, Imai Y, Penninger JM. Angiotensin-converting enzyme 2 in lung diseases. Curr Opin Pharmacol. 2006;6:271\u20136.","journal-title":"Curr Opin Pharmacol"},{"key":"808_CR23","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/nature00786","volume":"417","author":"M Crackower","year":"2002","unstructured":"Crackower M, Sarao R, Oudit G, et al. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature. 2002;417:822\u20138.","journal-title":"Nature"},{"key":"808_CR24","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1161\/01.HYP.0000060689.38912.CB","volume":"41","author":"C Tikellis","year":"2003","unstructured":"Tikellis C, Johnston CI, Forbes JM, et al. Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy. Hypertension. 2003;41:392\u20137.","journal-title":"Hypertension"},{"key":"808_CR25","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1038\/s41591-019-0468-5","volume":"25","author":"FA Vieira Braga","year":"2019","unstructured":"Vieira Braga FA, Kar G, Berg M, et al. A cellular census of human lungs identifies novel cell states in health and in asthma. Nat Med. 2019;25:1153\u201363.","journal-title":"Nat Med"},{"issue":"20","key":"808_CR26","doi-asserted-by":"publisher","first-page":"e90558","DOI":"10.1172\/jci.insight.90558","volume":"1","author":"Y Xu","year":"2016","unstructured":"Xu Y, Mizuno T, Sridharan A, et al. Single-cell RNA sequencing identifies diverse roles of epithelial cells in idiopathic pulmonary fibrosis. JCI Insight. 2016;1(20):e90558.","journal-title":"JCI Insight"},{"key":"808_CR27","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1093\/eurheartj\/ehi114","volume":"26","author":"LM Burrell","year":"2005","unstructured":"Burrell LM, Risvanis J, Kubota E, et al. Myocardial infarction increases ACE2 expression in rat and humans. Eur Heart J. 2005;26:369\u201375.","journal-title":"Eur Heart J"},{"key":"808_CR28","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1136\/gut.2004.062398","volume":"54","author":"G Paizis","year":"2005","unstructured":"Paizis G, Tikellis C, Cooper ME, et al. Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2. Gut. 2005;54:1790\u20136.","journal-title":"Gut"},{"key":"808_CR29","first-page":"1277","volume":"13","author":"H Mou","year":"2013","unstructured":"Mou H, Raj VS, van Kuppeveld FJM, et al. The receptor binding domain of the new MERS coronavirus maps to a 231-residue region in the spike protein that efficiently elicits neutralizing antibodies. J Virol. 2013;13:1277\u2013313.","journal-title":"J Virol"},{"key":"808_CR30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.phrs.2017.06.005","volume":"125","author":"XC Li","year":"2017","unstructured":"Li XC, Zhang J, Zhuo JL. The vasoprotective axes of the renin-angiotensin system: physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases. Pharmacol Res. 2017;125:21\u201338.","journal-title":"Pharmacol Res"},{"key":"808_CR31","doi-asserted-by":"publisher","DOI":"10.1101\/2020.01.26.919985","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Zhao Z, Wang Y, et al. Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov. BioRxiv. 2020. https:\/\/doi.org\/10.1101\/2020.01.26.919985.","journal-title":"BioRxiv"},{"issue":"4","key":"808_CR32","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/PII","volume":"8","author":"L Fang","year":"2020","unstructured":"Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med. 2020;8(4):e21. https:\/\/doi.org\/10.1016\/PII.","journal-title":"Lancet Respir Med"},{"key":"808_CR33","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.bbrc.2020.02.071","volume":"525","author":"Y Chen","year":"2020","unstructured":"Chen Y, Guo Y, Pan Y, et al. Structure analysis of the receptor binding of 2019-nCoV. Biochem Biophys Res Commun. 2020;525:135\u201340.","journal-title":"Biochem Biophys Res Commun"},{"key":"808_CR34","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nature03712","volume":"436","author":"Y Imai","year":"2005","unstructured":"Imai Y, Kuba K, Rao S, et al. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature. 2005;436:112\u20136.","journal-title":"Nature"},{"key":"808_CR35","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1007\/s12250-020-00205-6","volume":"35","author":"Y Wu","year":"2020","unstructured":"Wu Y. Compensation of ACE2 function for possible clinical management of 2019-nCoV-induced acute lung injury. Virol Sin. 2020;35:256\u20138. https:\/\/doi.org\/10.1007\/s12250-020-00205-6.","journal-title":"Virol Sin"},{"key":"808_CR36","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/nm1267","volume":"11","author":"K Kuba","year":"2005","unstructured":"Kuba K, Imai Y, Rao S, et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med. 2005;11:875\u20139.","journal-title":"Nat Med"},{"key":"808_CR37","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.taap.2010.02.009","volume":"245","author":"SX Han","year":"2010","unstructured":"Han SX, He GM, Wang T, et al. Losartan attenuates chronic cigarette smoke exposure-induced pulmonary arterial hypertension in rats: possible involvement of angiotensin-converting enzyme-2. Toxicol Appl Pharmacol. 2010;245:100\u20137.","journal-title":"Toxicol Appl Pharmacol"},{"key":"808_CR38","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1093\/eurheartj\/ehaa373","volume":"41","author":"IE Sama","year":"2020","unstructured":"Sama IE, Ravera A, Santema BT, et al. Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors. Eur Heart J. 2020;41:1810\u20137. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa373.","journal-title":"Eur Heart J"},{"issue":"7","key":"808_CR39","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1001\/jamacardio.2020.1017","volume":"5","author":"T Guo","year":"2020","unstructured":"Guo T, Fan Y, Chen M, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(7):811\u20138. https:\/\/doi.org\/10.1001\/jamacardio.2020.1017(Published online March 27, 2020).","journal-title":"JAMA Cardiol."},{"issue":"9","key":"808_CR40","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1001\/jamacardio.2020.1855","volume":"5","author":"N Mehta","year":"2020","unstructured":"Mehta N, Kalra A, Nowacki AS, et al. Association of use of angiotensin-converting enzyme inhibitors and angiotensin II receptor with testing positive for coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(9):1020\u20136. https:\/\/doi.org\/10.1001\/jamacardio.2020.1855.","journal-title":"JAMA Cardiol"},{"issue":"7","key":"808_CR41","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1001\/jamacardio.2020.1624","volume":"5","author":"J Li","year":"2020","unstructured":"Li J, Wang X, Chen J, Zhang H, Deng A. Association of renin-angiotensin system inhibitors with severity or risk of death in patients with hypertension hospitalized for coronavirus disease 2019 (COVID-19) infection in Wuhan, China. JAMA Cardiol. 2020;5(7):825\u201330. https:\/\/doi.org\/10.1001\/jamacardio.2020.1624.","journal-title":"JAMA Cardiol"},{"issue":"25","key":"808_CR42","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1056\/NEJMoa2008975","volume":"382","author":"H Reynolds","year":"2020","unstructured":"Reynolds H, Samrachana A, Pulgarin C, Troxel AB, et al. Renin-angiotensin-aldosterone system inhibitors and risk of Covid-19. N Engl J Med. 2020;382(25):2441\u20138. https:\/\/doi.org\/10.1056\/NEJMoa2008975.","journal-title":"N Engl J Med"},{"issue":"25","key":"808_CR43","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1056\/NEJMoa2006923","volume":"382","author":"G Mancia","year":"2020","unstructured":"Mancia G, Rea F, Ludergnani M, et al. Renin-angiotensin-aldosterone system blockers and the risk of Covid-19. N Engl J Med. 2020;382(25):2431\u201340. https:\/\/doi.org\/10.1056\/NEJMoa2006923.","journal-title":"N Engl J Med"},{"issue":"25","key":"808_CR44","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1056\/NEJMoa2007621","volume":"382","author":"MR Mehra","year":"2020","unstructured":"Mehra MR, Desai SS, Kuy SR, et al. Cardiovascular disease, drug therapy, and mortality in Covid-19. N Engl J Med. 2020;382(25):e102. https:\/\/doi.org\/10.1056\/NEJMoa2007621.","journal-title":"N Engl J Med"},{"issue":"10238","key":"808_CR45","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1016\/S0140-6736(20)31030-8","volume":"395","author":"F De Abajo","year":"2020","unstructured":"De Abajo F, Rodriguez-Martin S, Lema V, et al. Use of renin-angiotensin-aldosterone system inhibitors and risk of Covid-19 requiring admission to hospital: a case-population study. The Lancet. 2020;395(10238):1705\u201314. https:\/\/doi.org\/10.1016\/S0140-6736(20)31030-8.","journal-title":"The Lancet"},{"issue":"12","key":"808_CR46","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1161\/CIRCRESAHA.120.317134","volume":"126","author":"P Zhang","year":"2020","unstructured":"Zhang P, Zhu L, Cai J, Lei F, et al. Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II blockers with mortality among patients with hypertension hospitalized with COVID-19. Circ Res. 2020;126(12):1671\u201381. https:\/\/doi.org\/10.1161\/CIRCRESAHA.120.317134.","journal-title":"Circ Res"},{"issue":"1","key":"808_CR47","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1080\/22221751.2020.1746200","volume":"9","author":"J Meng","year":"2020","unstructured":"Meng J, Xiao G, Zhang J, He X, et al. Renin-angiotensin system inhibitors improve the clinical outcome of COVID-19 patients with hypertension. Emerg Microb Infect. 2020;9(1):757\u201360. https:\/\/doi.org\/10.1080\/22221751.2020.1746200.","journal-title":"Emerg Microb Infect"},{"issue":"3","key":"808_CR48","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.jacc.2020.05.040","volume":"76","author":"J Amat-Santos","year":"2020","unstructured":"Amat-Santos J, Santos-Martinez S, L\u00f3pez-Otero D, Nombela-Franco L, et al. Ramipril in high-risk patients with COVID-19. J Am Coll Cardiol. 2020;76(3):268\u201376.","journal-title":"J Am Coll Cardiol"},{"key":"808_CR49","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1056\/NEJMsr2005760","volume":"382","author":"M Vaduganathan","year":"2020","unstructured":"Vaduganathan M, Vardeny O, Michel T, McMurray JJV, Pfeffer MA, Solomon SD. Renin\u2013angiotensin\u2013aldosterone system inhibitors in patients with Covid-19. N Engl J Med. 2020;382:1653\u20139.","journal-title":"N Engl J Med"},{"key":"808_CR50","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/nm1267","volume":"11","author":"K Kuba","year":"2005","unstructured":"Kuba K, Imai Y, Rao S, et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus\u2013induced lung injury. Nat Med. 2005;11:875\u20139.","journal-title":"Nat Med"},{"issue":"5","key":"808_CR51","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1172\/JCI137647","volume":"130","author":"SF Pedersen","year":"2020","unstructured":"Pedersen SF, Ho YC. SARS-CoV-2: a storm is raging. J Clin Invest. 2020;130(5):2202\u20135. https:\/\/doi.org\/10.1172\/JCI137647.","journal-title":"J Clin Invest"},{"key":"808_CR52","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","volume":"395","author":"P Mehta","year":"2020","unstructured":"Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395:1033\u20134.","journal-title":"Lancet"},{"key":"808_CR53","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497\u2013506.","journal-title":"Lancet"},{"issue":"5","key":"808_CR54","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","volume":"8","author":"X Yang","year":"2020","unstructured":"Yang X, Yu Y, Xu J, Shu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475\u201381. https:\/\/doi.org\/10.1016\/S2213-2600(20)30079-5.","journal-title":"Lancet Respir Med"},{"issue":"10","key":"808_CR55","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41574-018-0059-4","volume":"14","author":"C Franceschi","year":"2018","unstructured":"Franceschi C, Garagnani P, Parini P, Giuliani C, Santoro A, Franceschi C, et al. Inflammaging: a new immune-metabolic viewpoint for age-related diseases. Nat Rev Endocrinol. 2018;14(10):576\u201390.","journal-title":"Nat Rev Endocrinol."},{"key":"808_CR56","doi-asserted-by":"publisher","first-page":"e48401","DOI":"10.7554\/eLife.48401","volume":"9","author":"CE Brook","year":"2020","unstructured":"Brook CE, Boots M, Chandran K, et al. Accelerated viral dynamics in bat cell lines, with implications for zoonotic emergence. Elife. 2020;9:e48401. https:\/\/doi.org\/10.7554\/eLife.48401.","journal-title":"Elife"},{"issue":"5","key":"808_CR57","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/S1473-3099(20)30235-8","volume":"20","author":"Y Chen","year":"2020","unstructured":"Chen Y, Li L. SARS-CoV-2: virus dynamics and host response. Lancet Infect Dis. 2020;20(5):515\u20136. https:\/\/doi.org\/10.1016\/S1473-3099(20)30235-8.","journal-title":"Lancet Infect Dis"},{"issue":"25","key":"808_CR58","doi-asserted-by":"publisher","first-page":"e11152","DOI":"10.1097\/MD.0000000000011152","volume":"97","author":"X He","year":"2018","unstructured":"He X, Li Z, Tang X, Zhang L, et al. Age- and sex-related differences in body composition in healthy subjects aged 18 to 82 years. Med (Baltim). 2018;97(25):e11152. https:\/\/doi.org\/10.1097\/MD.0000000000011152.","journal-title":"Med (Baltim)"},{"issue":"3","key":"808_CR59","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/path.5471","volume":"251","author":"AR Bourgonje","year":"2020","unstructured":"Bourgonje AR, Abdulle AE, Timens W, et al. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19). J Pathol. 2020;251(3):228\u201348. https:\/\/doi.org\/10.1002\/path.5471.","journal-title":"J Pathol"},{"key":"808_CR60","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1093\/ehjcvp\/pvaa028","volume":"6","author":"D Acanfora","year":"2020","unstructured":"Acanfora D, Ciccone MM, Scicchitano P, Acanfora C, Casucci G. Neprilysin inhibitor\u2013angiotensin II receptor blocker combination (sacubitril\/valsartan): rationale for adoption in SARS-CoV-2 patients. Eur Heart J Cardiovasc Pharmacother. 2020;6:135\u20136. https:\/\/doi.org\/10.1093\/ehjcvp\/pvaa028.","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"808_CR61","doi-asserted-by":"publisher","first-page":"6509","DOI":"10.1038\/s41598-019-42994-1","volume":"9","author":"H Zhang","year":"2019","unstructured":"Zhang H, Liu G, Zhou W, Zhang W, Wang K, Zhang J. Neprilysin inhibitor\u2013angiotensin II receptor blocker combination therapy (sacubitril\/valsartan) suppresses atherosclerotic plaque formation and inhibits inflammation in apolipoprotein E-deficient Mice. Sci Rep. 2019;9:6509.","journal-title":"Sci Rep"},{"issue":"5","key":"808_CR62","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s40261-020-00908-4","volume":"40","author":"D Acanfora","year":"2020","unstructured":"Acanfora D, Scicchitano P, Acanfora C, Maestri R, Goglia F, Incalzi RA, et al. Early initiation of sacubitril\/valsartan in patients with chronic heart failure after acute decompensation: a case series analysis. Clin Drug Investig. 2020;40(5):493\u2013501. https:\/\/doi.org\/10.1007\/s40261-020-00908-4.","journal-title":"Clin Drug Investig"}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-020-00808-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-020-00808-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-020-00808-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T00:34:32Z","timestamp":1634776472000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-020-00808-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,21]]},"references-count":62,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["808"],"URL":"https:\/\/doi.org\/10.1007\/s40266-020-00808-4","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,21]]},"assertion":[{"value":"30 September 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No external funding was used in the preparation of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Gerardo Casucci, Domenico Acanfora, and Raffaele Antonelli Incalzi declare they have no potential conflicts of interest that might be relevant to the contents of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest\/Competing Interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"Conception and design: Gerardo Casucci, Domenico Acanfora and Raffaele Antonelli Incalzi. Literature search, draft and\/or critical revision of the work and approval of the final manuscript: All authors.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}